☆ 4.5 Article

Tumor Heterogeneity and Drug Resistance Mutations Using ctDNA in Metastatic EGFR Mutation-Positive Lung Adenocarcinoma: A Case Report

ONCOTARGETS AND THERAPY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Review Oncology

Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy

Nader El-Sayes et al.

Summary: Tumor heterogeneity remains a major obstacle in successful cancer treatment, arising from changes in the tumor microenvironment and leading to the presence of different malignant subpopulations within a single tumor mass. Therapeutic interventions can increase selective pressure towards resistant subpopulations, often causing relapse in previously responsive patients. Strategies such as multi-therapy regimens are being employed to combat intrinsic resistance mechanisms, especially in the field of cancer immunotherapy, where antigen escape and immunosuppression are common forms of acquired resistance.

CANCERS (2021)

添加到收藏夹

Article Oncology

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer

Fei Ma et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

添加到收藏夹

Review Genetics & Heredity

Clinical implications of intratumor heterogeneity: challenges and opportunities

Santiago Ramon y Cajal et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2020)

添加到收藏夹

Review Oncology

The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal

Valerio Gristina et al.

CANCER TREATMENT REVIEWS (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy

Marzia Del Re et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

添加到收藏夹

Review Oncology

Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy

Zuan-Fu Lim et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

添加到收藏夹

Article Oncology

A study of tumor heterogeneity in a case with breast cancer

Haruka Nakada et al.

BREAST CANCER (2017)

添加到收藏夹

Article Oncology

Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients

L. Sorber et al.

LUNG CANCER (2017)

添加到收藏夹

Article Medicine, General & Internal

Tracking the Evolution of Non-Small-Cell Lung Cancer

M. Jamal-Hanjani et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Genomic heterogeneity of multiple synchronous lung cancer

Yu Liu et al.

NATURE COMMUNICATIONS (2016)

添加到收藏夹

Article Oncology

AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer

Darren A. E. Cross et al.

CANCER DISCOVERY (2014)

添加到收藏夹

Review Oncology

Cancer heterogeneity: implications for targeted therapeutics

R. Fisher et al.

BRITISH JOURNAL OF CANCER (2013)

添加到收藏夹

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

CELL (2011)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.